|
schizophrenia |
115 |
|
depression |
109 |
|
covid-19 |
93 |
|
humans |
92 |
|
adult |
81 |
|
female |
79 |
|
hong kong |
76 |
|
male |
71 |
|
psychosis |
71 |
|
adolescent |
68 |
|
chinese |
68 |
|
aged |
60 |
|
risk factors |
60 |
|
middle aged |
57 |
|
mental health |
56 |
|
anxiety |
55 |
|
first-episode psychosis |
55 |
|
genetic predisposition to disease |
51 |
|
youth mental health |
51 |
|
dementia |
50 |
|
depressive symptoms |
50 |
|
genotype |
49 |
|
asian continental ancestry group - genetics |
47 |
|
epidemiology |
47 |
|
polymorphism, single nucleotide |
47 |
|
psychotic disorders |
46 |
|
randomized controlled trial |
46 |
|
meta-analysis |
45 |
|
negative symptoms |
45 |
|
medical sciences |
42 |
|
early intervention |
40 |
|
older adults |
40 |
|
young adult |
40 |
|
genome-wide association study |
37 |
|
early psychosis |
36 |
|
physical activity |
36 |
|
prevalence |
36 |
|
antipsychotics |
35 |
|
insomnia |
35 |
|
bipolar disorder |
34 |
|
polymorphism, single nucleotide - genetics |
34 |
|
sleep |
34 |
|
mortality |
33 |
|
cognition |
32 |
|
functioning |
32 |
|
age factors |
31 |
|
china |
31 |
|
cognitive impairment |
31 |
|
first-episode schizophrenia |
31 |
|
psychopathology |
31 |
|
child |
30 |
|
genetic association |
30 |
|
mindfulness |
30 |
|
network analysis |
29 |
|
predictors |
29 |
|
relapse |
29 |
|
stress |
29 |
|
cost-effectiveness |
28 |
|
genetics |
28 |
|
hong kong - epidemiology |
28 |
|
incidence |
28 |
|
interprofessional education |
28 |
|
partnership model |
28 |
|
sex factors |
28 |
|
social interaction anxiety |
28 |
|
stigma |
28 |
|
acupuncture |
27 |
|
cancer |
27 |
|
dopamine |
27 |
|
first episode |
27 |
|
psychiatry and neurology |
27 |
|
executive function |
26 |
|
exercise |
26 |
|
mendelian randomization |
26 |
|
quality of life |
26 |
|
social unrest |
26 |
|
systematic review |
26 |
|
cohort studies |
25 |
|
magnetic resonance imaging |
25 |
|
prevention |
25 |
|
recurrence |
25 |
|
remission |
25 |
|
single nucleotide polymorphism |
25 |
|
association |
24 |
|
atrial fibrillation |
24 |
|
controlled study |
24 |
|
longitudinal study |
24 |
|
risk factor |
24 |
|
sars-cov-2 |
24 |
|
suicide |
24 |
|
time factors |
24 |
|
adolescents |
23 |
|
cognitive function |
23 |
|
human |
23 |
|
loneliness |
23 |
|
post-traumatic stress disorder |
23 |
|
prognosis |
23 |
|
assessment |
22 |
|
case-control studies |
22 |
|
cluster analysis |
22 |
|
duration of untreated psychosis |
22 |
|
hospitalization |
22 |
|
rumination |
22 |
|
vitamin d |
22 |
|
animals |
21 |
|
cell adhesion molecules - genetics |
21 |
|
gene frequency |
21 |
|
longitudinal |
21 |
|
mri |
21 |
|
schizophrenic psychology |
21 |
|
aged, 80 and over |
20 |
|
asian continental ancestry group |
20 |
|
comorbidity |
20 |
|
gwas |
20 |
|
insight |
20 |
|
ischemic stroke |
20 |
|
mental health services |
20 |
|
qigong |
20 |
|
questionnaires |
20 |
|
rct |
20 |
|
treatment outcome |
20 |
|
type 2 diabetes |
20 |
|
age of onset |
19 |
|
amotivation |
19 |
|
coronary artery disease |
19 |
|
disease progression |
19 |
|
elderly |
19 |
|
first-episode |
19 |
|
medication adherence |
19 |
|
priority journal |
19 |
|
age distribution |
18 |
|
antigens, cd - genetics |
18 |
|
development |
18 |
|
functional outcome |
18 |
|
gene expression regulation, neoplastic |
18 |
|
obesity |
18 |
|
pandemic |
18 |
|
psychiatric status rating scales |
18 |
|
severity of illness index |
18 |
|
social support |
18 |
|
whole-exome sequencing |
18 |
|
antidepressants |
17 |
|
body mass index |
17 |
|
cross-sectional studies |
17 |
|
diffusion tensor imaging |
17 |
|
longitudinal studies |
17 |
|
major clinical study |
17 |
|
memory |
17 |
|
population-based |
17 |
|
resilience |
17 |
|
antipsychotic agents - therapeutic use |
16 |
|
avolition |
16 |
|
brain - pathology |
16 |
|
caregivers |
16 |
|
child psychosocial problems |
16 |
|
clozapine |
16 |
|
copy number variation |
16 |
|
coronavirus |
16 |
|
delusional disorder |
16 |
|
employment |
16 |
|
epidemiological study |
16 |
|
experience sampling method |
16 |
|
home confinement |
16 |
|
mental disorders |
16 |
|
neuropsychological tests |
16 |
|
prediction |
16 |
|
pregnancy |
16 |
|
promoter regions, genetic |
16 |
|
psychotic-like experiences |
16 |
|
public health |
16 |
|
school closure |
16 |
|
sleep disturbance |
16 |
|
social cognition |
16 |
|
suicidal ideation |
16 |
|
adherence |
15 |
|
aging |
15 |
|
alzheimer's disease |
15 |
|
anhedonia |
15 |
|
asian |
15 |
|
children |
15 |
|
complications |
15 |
|
diabetes mellitus |
15 |
|
follow-up studies |
15 |
|
frailty |
15 |
|
gene identification |
15 |
|
gene locus |
15 |
|
hypertension |
15 |
|
l-lactate dehydrogenase - blood |
15 |
|
linkage disequilibrium |
15 |
|
major depressive disorder |
15 |
|
mice |
15 |
|
neuregulin-1 - genetics |
15 |
|
predictive value of tests |
15 |
|
review |
15 |
|
self-stigma |
15 |
|
theory of mind |
15 |
|
validation |
15 |
|
adverse events |
14 |
|
alleles |
14 |
|
antipsychotic |
14 |
|
autism spectrum disorder |
14 |
|
chemicals and cas registry numbers |
14 |
|
child, preschool |
14 |
|
coronavirus infection |
14 |
|
diagnosis |
14 |
|
effectiveness |
14 |
|
gender |
14 |
|
gene expression |
14 |
|
genetic variation |
14 |
|
haplotypes |
14 |
|
health outcomes |
14 |
|
hippocampus |
14 |
|
likelihood functions |
14 |
|
metabolic syndrome |
14 |
|
neurocognition |
14 |
|
outcome |
14 |
|
peer support |
14 |
|
psychotic disorders - diagnosis |
14 |
|
ptsd symptoms |
14 |
|
recovery |
14 |
|
reliability |
14 |
|
sars |
14 |
|
smartphone overuse |
14 |
|
systemic lupus erythematosus |
14 |
|
working memory |
14 |
|
bile duct atresia |
13 |
|
cancer susceptibility genes |
13 |
|
china - epidemiology |
13 |
|
chromosome 10q |
13 |
|
classification |
13 |
|
collaborative stepped care |
13 |
|
diminished expression |
13 |
|
early diagnosis |
13 |
|
early-age onset |
13 |
|
endophenotype |
13 |
|
functional connectivity |
13 |
|
gene function |
13 |
|
genetic susceptibility |
13 |
|
genome-wide association |
13 |
|
hepatocellular carcinoma |
13 |
|
hirschsprung disease |
13 |
|
hirschsprung disease - genetics |
13 |
|
interleukin-6 |
13 |
|
lipocalin-2 |
13 |
|
lithium |
13 |
|
machine learning |
13 |
|
magnetic resonance imaging - methods |
13 |
|
mild cognitive impairment |
13 |
|
mindfulness-based intervention |
13 |
|
mst1r |
13 |
|
nasopharyngeal carcinoma |
13 |
|
personality |
13 |
|
premorbid adjustment |
13 |
|
prospective study |
13 |
|
receptors, cell surface - genetics |
13 |
|
regression analysis |
13 |
|
risk prediction |
13 |
|
schizotypal personality disorder |
13 |
|
secondary prevention |
13 |
|
symptomatology |
13 |
|
validation study |
13 |
|
violence |
13 |
|
web-based |
13 |
|
young people |
13 |
|
youth |
13 |
|
adhd |
12 |
|
affect |
12 |
|
animal tissue |
12 |
|
anorectal malformation |
12 |
|
anxiety disorder |
12 |
|
attitude |
12 |
|
brain |
12 |
|
chromosome aberration |
12 |
|
community |
12 |
|
cos cells |
12 |
|
diabetic retinopathy |
12 |
|
early detection |
12 |
|
electrophoretic mobility shift assay |
12 |
|
ephrin-a2 - genetics |
12 |
|
evaluation |
12 |
|
gene mapping |
12 |
|
genetic predisposition to disease - genetics |
12 |
|
gwa |
12 |
|
intervention |
12 |
|
lupus erythematosus, systemic - genetics |
12 |
|
maintenance |
12 |
|
momentary positive affect |
12 |
|
mutation - genetics |
12 |
|
mutations |
12 |
|
myocardial infarction |
12 |
|
placebo |
12 |
|
pleiotropy |
12 |
|
poisson distribution |
12 |
|
prospective studies |
12 |
|
relapse prevention |
12 |
|
ret |
12 |
|
reverse transcriptase polymerase chain reaction |
12 |
|
schizophrenia - complications |
12 |
|
self-help |
12 |
|
severe acute respiratory syndrome - blood - genetics |
12 |
|
sle |
12 |
|
snp |
12 |
|
socioeconomic factors |
12 |
|
stressful life events |
12 |
|
survival |
12 |
|
uhrf1bp1 |
12 |
|
united states - epidemiology |
12 |
|
wnt signaling pathway |
12 |
|
antigens, cd3 - genetics |
11 |
|
asia |
11 |
|
bmd |
11 |
|
breast cancer |
11 |
|
cd247 |
11 |
|
databases, genetic |
11 |
|
delirium |
11 |
|
diabetes |
11 |
|
ethnic group |
11 |
|
gene mutation |
11 |
|
genetic polymorphism |
11 |
|
genetic predisposition |
11 |
|
genome-wide association studies |
11 |
|
genomics |
11 |
|
heritability |
11 |
|
heterozygote |
11 |
|
human tissue |
11 |
|
infant |
11 |
|
influenza |
11 |
|
kw034 - copy number/structural variation |
11 |
|
life expectancy |
11 |
|
long-term outcomes |
11 |
|
longitudinal follow-up |
11 |
|
lupus erythematosus, systemic - genetics - immunology |
11 |
|
maintenance treatment |
11 |
|
mass screening |
11 |
|
neuropsychology |
11 |
|
nucleotide sequence |
11 |
|
odds ratio |
11 |
|
oncology |
11 |
|
osteoporosis |
11 |
|
pattern glare |
11 |
|
perceptual distortions |
11 |
|
polymorphism, genetic |
11 |
|
positron emission tomography |
11 |
|
processing speed |
11 |
|
prospective follow-up |
11 |
|
risk |
11 |
|
risk assessment |
11 |
|
schizotypy |
11 |
|
self-acupressure |
11 |
|
self-reference |
11 |
|
sex difference |
11 |
|
treatment |
11 |
|
treatment adherence |
11 |
|
validity |
11 |
|
voxel-based morphometry |
11 |
|
whole exome sequencing |
11 |
|
25-hydroxyvitamin d |
10 |
|
adipocyte |
10 |
|
algorithms |
10 |
|
amino acid substitution |
10 |
|
anxiety symptoms |
10 |
|
b-type natriuretic peptide |
10 |
|
biomarkers |
10 |
|
bone density - genetics |
10 |
|
cardiac troponin |
10 |
|
causality |
10 |
|
cell adhesion molecules - genetics - metabolism |
10 |
|
cognitive decline |
10 |
|
cognitive functions |
10 |
|
cohort study |
10 |
|
community-based intervention |
10 |
|
computer simulation |
10 |
|
covid-19 vaccine |
10 |
|
delusions |
10 |
|
depressive mood |
10 |
|
diabetes complications |
10 |
|
discontinuation |
10 |
|
disengagement |
10 |
|
double blind |
10 |
|
dsm-5 |
10 |
|
exome chip |
10 |
|
f-dopa |
10 |
|
family health |
10 |
|
fibroblast growth factor |
10 |
|
first episode psychosis |
10 |
|
genetics, population |
10 |
|
genome scan |
10 |
|
genotype-phenotype correlations |
10 |
|
inflammation |
10 |
|
intracellular signaling peptides and proteins - genetics |
10 |
|
lactate dehydrogenase |
10 |
|
language |
10 |
|
lumbar disc degeneration |
10 |
|
lupus erythematosus, systemic - enzymology - genetics |
10 |
|
major depressive episode |
10 |
|
mapping complex traits |
10 |
|
mental health literacy |
10 |
|
models, statistical |
10 |
|
momentary assessment |
10 |
|
nuclear proteins - genetics - metabolism |
10 |
|
pasc |
10 |
|
post-acute sequelae of sars-cov-2 |
10 |
|
protein binding - genetics |
10 |
|
rare complex disease |
10 |
|
registries |
10 |
|
reproducibility of results |
10 |
|
reward |
10 |
|
schizophrenia - diagnosis |
10 |
|
screening |
10 |
|
second-generation antipsychotics |
10 |
|
sex differences |
10 |
|
social context |
10 |
|
stereotyping |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
survival rate |
10 |
|
temporal trends |
10 |
|
traditional chinese medicine |
10 |
|
transcription factors - genetics - metabolism |
10 |
|
type 2 diabetes mellitus |
10 |
|
vaccine safety |
10 |
|
vitamin d-binding protein |
10 |
|
youth-friendly |
10 |
|
acupressure |
9 |
|
adolescence |
9 |
|
air pollution |
9 |
|
amygdala |
9 |
|
asian-specific |
9 |
|
association study |
9 |
|
autistic disorder |
9 |
|
balloon analogue risk task |
9 |
|
bipolar |
9 |
|
cardiovascular disease |
9 |
|
caudate |
9 |
|
chromosomes, human, pair 6 - genetics |
9 |
|
cognition disorders - etiology |
9 |
|
cognitive dysfunction |
9 |
|
cohort |
9 |
|
delusions - etiology |
9 |
|
dti |
9 |
|
early medical intervention - methods - trends |
9 |
|
electroacupuncture |
9 |
|
epidemiologic methods |
9 |
|
epidemiological youth |
9 |
|
esm |
9 |
|
excess life-years lost |
9 |
|
exome-chip association analysis |
9 |
|
expression quantitative trait loci |
9 |
|
fractional anisotropy |
9 |
|
fracture |
9 |
|
gender difference |
9 |
|
gene |
9 |
|
genetic correlation |
9 |
|
hallucination |
9 |
|
health education - methods |
9 |
|
ideas of reference |
9 |
|
internalized stigma |
9 |
|
ketamine |
9 |
|
latent class growth analysis |
9 |
|
life events |
9 |
|
linkage |
9 |
|
lumbar vertebrae |
9 |
|
mass screening - methods |
9 |
|
mental health services - trends |
9 |
|
methamphetamine |
9 |
|
motivational deficits |
9 |
|
mutation |
9 |
|
natural selection |
9 |
|
omicron |
9 |
|
panss |
9 |
|
pax4 |
9 |
|
pedigree |
9 |
|
premature mortality |
9 |
|
prodrome |
9 |
|
program development |
9 |
|
psychotic disorders - therapy |
9 |
|
public stigma |
9 |
|
randomised controlled trial |
9 |
|
rare variants |
9 |
|
receptors, calcitriol - genetics |
9 |
|
schizophrenia - pathology |
9 |
|
self |
9 |
|
semantic |
9 |
|
sex characteristics |
9 |
|
sex disparity |
9 |
|
smoking |
9 |
|
social functioning |
9 |
|
software |
9 |
|
stability |
9 |
|
stigmatization |
9 |
|
survey |
9 |
|
tai chi |
9 |
|
transcranial direct current stimulation |
9 |
|
traumatic events |
9 |
|
young-onset ischemic stroke |
9 |
|
actigraphy |
8 |
|
adiponectin - blood - genetics |
8 |
|
adults |
8 |
|
age-period-cohort |
8 |
|
alcoholism |
8 |
|
allelic imbalance |
8 |
|
asian continental ancestry group - ethnology |
8 |
|
at-risk mental state |
8 |
|
attention deficit hyperactivity disorder |
8 |
|
bioinformatics |
8 |
|
blood pressure - genetics |
8 |
|
brain - ultrastructure |
8 |
|
breast neoplasms |
8 |
|
cdars |
8 |
|
cell adhesion molecules - genetics - physiology |
8 |
|
cell differentiation - physiology |
8 |
|
chi-square distribution |
8 |
|
children & adolescents |
8 |
|
colorectal cancer |
8 |
|
computational biology |
8 |
|
corpus striatum |
8 |
|
cost of illness |
8 |
|
culture |
8 |
|
cyclin a2 |
8 |
|
degeneration |
8 |
|
degenerative disc disease |
8 |
|
delusions - diagnosis |
8 |
|
disc |
8 |
|
discriminant analysis |
8 |
|
disease models, animal |
8 |
|
disease outbreaks - statistics & numerical data |
8 |
|
disease susceptibility |
8 |
|
dna mutational analysis |
8 |
|
dose-dependent effect |
8 |
|
double-blind method |
8 |
|
drug-naive |
8 |
|
dsm-iv-tr |
8 |
|
ecological momentary assessment |
8 |
|
environment |
8 |
|
european continental ancestry group - statistics & numerical data |
8 |
|
exercise - physiology |
8 |
|
eye-gaze perception |
8 |
|
functional mri |
8 |
|
gene deletion |
8 |
|
gene duplication |
8 |
|
gene expression regulation |
8 |
|
gene frequency - genetics |
8 |
|
genetic variants |
8 |
|
genetic variation - genetics |
8 |
|
growth mixture modeling |
8 |
|
haplotype |
8 |
|
hbv integration |
8 |
|
hcc |
8 |
|
hedgehog proteins - genetics - metabolism |
8 |
|
hirschsprung disease - genetics - physiopathology |
8 |
|
homozygote |
8 |
|
hypertension - blood - genetics |
8 |
|
icd-10 |
8 |
|
icsd-2 |
8 |
|
infant, newborn |
8 |
|
insr |
8 |
|
insulin resistance - genetics |
8 |
|
intervertebral |
8 |
|
intervertebral disc degeneration |
8 |
|
interview, psychological - methods |
8 |
|
japan |
8 |
|
kw080 - genome-wide association |
8 |
|
latent class analysis |
8 |
|
lectins, c-type - genetics |
8 |
|
life tables |
8 |
|
long-term outcome |
8 |
|
lumbar |
8 |
|
maternal age |
8 |
|
maternal exposure |
8 |
|
mathematics |
8 |
|
mental health services - standards |
8 |
|
mentalization |
8 |
|
meta analysis |
8 |
|
mhealth |
8 |
|
mode of onset |
8 |
|
models, genetic |
8 |
|
multivariate analysis |
8 |
|
nasopharyngeal neoplasms - genetics |
8 |
|
network |
8 |
|
neurobiology |
8 |
|
neuroglia - cytology - physiology |
8 |
|
neurological soft signs |
8 |
|
obesity - genetics |
8 |
|
outbreak |
8 |
|
p300 |
8 |
|
pain |
8 |
|
path analysis |
8 |
|
persistent psychotic experience |
8 |
|
pharmacoepidemiology |
8 |
|
phenotyping |
8 |
|
polygenic score |
8 |
|
potassium channels, inwardly rectifying - genetics |
8 |
|
prenatal exome |
8 |
|
primary negative symptoms |
8 |
|
proliferative diabetic retinopathy |
8 |
|
promoter regions, genetic - genetics |
8 |
|
prospective memory |
8 |
|
proteins - genetics |
8 |
|
psychiatric comorbidity |
8 |
|
psychosocial |
8 |
|
psychotic disorder |
8 |
|
psychotic disorders - complications |
8 |
|
psychotic symptoms |
8 |
|
raclopride |
8 |
|
receptors, notch - genetics - metabolism |
8 |
|
sars virus - isolation and purification - pathogenicity |
8 |
|
schizophrenia - drug therapy - physiopathology |
8 |
|
schizophrenia - genetics |
8 |
|
self-discrepancy |
8 |
|
self-harm |
8 |
|
sensitivity and specificity |
8 |
|
severe acute respiratory syndrome - physiopathology - virology |
8 |
|
sight-threatening diabetic retinopathy |
8 |
|
single nucleotide polymorphisms |
8 |
|
single-nucleotide polymorphism |
8 |
|
spirituality |
8 |
|
splicing |
8 |
|
substance abuse |
8 |
|
temporal lobe - ultrastructure |
8 |
|
terminology as topic |
8 |
|
trauma exposure |
8 |
|
treatment resistant schizophrenia |
8 |
|
variants of unknown clinical significance |
8 |
|
5' untranslated regions - genetics |
7 |
|
adaptation, psychological |
7 |
|
adolescent idiopathic scoliosis |
7 |
|
aggression |
7 |
|
air pollution - adverse effects |
7 |
|
alkaline phosphatase |
7 |
|
als |
7 |
|
amino acid substitution - genetics |
7 |
|
analgesia |
7 |
|
anti-stigma campaigns |
7 |
|
antigens, cd11b - genetics |
7 |
|
antipsychotic agents - administration and dosage |
7 |
|
antipsychotic agents - pharmacology - therapeutic use |
7 |
|
anxiety disorders |
7 |
|
asian americans - statistics & numerical data |
7 |
|
asian continental ancestry group - ethnology - genetics |
7 |
|
attention |
7 |
|
attitude to health |
7 |
|
autism |
7 |
|
behavior |
7 |
|
behavior, animal |
7 |
|
behavioral symptoms - etiology - psychology - therapy |
7 |
|
benzodiazepines |
7 |
|
big five |
7 |
|
biliary |
7 |
|
biological markers |
7 |
|
biology |
7 |
|
biomarker |
7 |
|
blood pressure |
7 |
|
bone mineral density |
7 |
|
bone/joint abnormalities |
7 |
|
breast neoplasms - epidemiology |
7 |
|
breast neoplasms - epidemiology - ethnology - mortality |
7 |
|
c-reactive protein |
7 |
|
carcinoma, ductal, breast - epidemiology - ethnology - mortality |
7 |
|
cardiovascular diseases |
7 |
|
caregiving |
7 |
|
cartilage |
7 |
|
cartilage diseases - genetics |
7 |
|
categorization |
7 |
|
cd209 |
7 |
|
cell line |
7 |
|
cer1 |
7 |
|
charcot-marie-tooth |
7 |
|
charcot-marie-tooth disease - genetics - pathology - physiopathology |
7 |
|
chinese population |
7 |
|
cholangiogram |
7 |
|
chromosome mapping - methods |
7 |
|
chronotype |
7 |
|
cognitive flexibility |
7 |
|
cognitive structure |
7 |
|
col4a5 |
7 |
|
col4a6 |
7 |
|
complex traits and polygenic disorders |
7 |
|
connexins - genetics |
7 |
|
content-dependent process |
7 |
|
coping strategies |
7 |
|
correlates |
7 |
|
cortical thickness |
7 |
|
course |
7 |
|
dc-sign |
7 |
|
de novo mutations |
7 |
|
dementia and cognitive disorders |
7 |
|
developed countries - statistics & numerical data |
7 |
|
developmental |
7 |
|
diagnostic and statistical manual of mental disorders |
7 |
|
digitalization |
7 |
|
directed differentiation |
7 |
|
discrimination |
7 |
|
dna - metabolism |
7 |
|
dna probes - genetics |
7 |
|
duration of untreated psychosis (dup) |
7 |
|
educational status |
7 |
|
eeg |
7 |
|
effort-based decision-making |
7 |
|
effort-cost computation |
7 |
|
electromyography |
7 |
|
electronic health record |
7 |
|
electronic health records |
7 |
|
emotion |
7 |
|
endophenotypes |
7 |
|
ens |
7 |
|
euclidean distance analysis |
7 |
|
executive function - physiology |
7 |
|
exome |
7 |
|
extended early intervention |
7 |
|
extracellular matrix proteins - chemistry - genetics |
7 |
|
extracellular matrix proteins - genetics - physiology |
7 |
|
facial emotion perception |
7 |
|
fatty acid-binding proteins - blood |
7 |
|
first-episode mania |
7 |
|
first-episode schizophrenia spectrum disorder |
7 |
|
fmri |
7 |
|
functional remission |
7 |
|
gene library |
7 |
|
genes |
7 |
|
genetic diseases, x-linked - genetics |
7 |
|
genetic mapping |
7 |
|
genome |
7 |
|
gjb1 (connexin32) |
7 |
|
gonosomal mosaicism |
7 |
|
han chinese |
7 |
|
haplotypes - genetics |
7 |
|
health economic analysis |
7 |
|
health service accessibility |
7 |
|
health surveys |
7 |
|
hela cells |
7 |
|
help-seeking |
7 |
|
help‐seeking |
7 |
|
human induced pluripotent stem cells |
7 |
|
identity |
7 |
|
illness disclosure |
7 |
|
influenza, human - complications - mortality - therapy |
7 |
|
integrative body-mind-spirit (ibms) |
7 |
|
internet |
7 |
|
intervertebral disc - pathology |
7 |
|
intervertebral disc disease |
7 |
|
intervertebral disk |
7 |
|
intervertebral disk displacement - complications - epidemiology - genetics |
7 |
|
interview, psychological |
7 |
|
interviews as topic |
7 |
|
isolated diffuse oesophageal leiomyomatosis |
7 |
|
kw040 - development |
7 |
|
kw065 - gastrointestinal system |
7 |
|
kw099 - malformation |
7 |
|
late-onset psychosis |
7 |
|
lateral ventricles |
7 |
|
lectins, c-type - genetics - metabolism |
7 |
|
letter |
7 |
|
life style |
7 |
|
life table |
7 |
|
linkage analysis |
7 |
|
lipids |
7 |
|
long-term follow-up |
7 |
|
longitudinal course |
7 |
|
lupus erythematosus, systemic - ethnology - genetics |
7 |
|
magnetic resonance cholangiography |
7 |
|
matrix metalloproteinase 1 - genetics |
7 |
|
medication-naïve |
7 |
|
mental health assessments |
7 |
|
mental health services - organization and administration |
7 |
|
microscopy, electron, transmission |
7 |
|
mood |
7 |
|
morbidity |
7 |
|
morphine consumption |
7 |
|
motivational impairment |
7 |
|
multi-method approach |
7 |
|
mutation detection |
7 |
|
nephritis - ethnology - genetics |
7 |
|
neural conduction - genetics - physiology |
7 |
|
neural crest |
7 |
|
neuregulin 1 |
7 |
|
neuropathy |
7 |
|
next generation sequencing |
7 |
|
nomenclature |
7 |
|
non-coding region |
7 |
|
notochord-like cells (ncls) |
7 |
|
nuclear proteins - metabolism |
7 |
|
nucleus pulposus (np)-like cells |
7 |
|
nursing home |
7 |
|
obstetric complications |
7 |
|
osteoarthritis |
7 |
|
overcontrolled |
7 |
|
parkinson's disease |
7 |
|
paternal age |
7 |
|
pathways |
7 |
|
peripheral nerves - pathology - physiopathology - ultrastructure |
7 |
|
persistent primary negative symptoms |
7 |
|
personal attributes |
7 |
|
pilot |
7 |
|
point mutation - genetics |
7 |
|
polymorphism |
7 |
|
post-complication mortality |
7 |
|
pre-existing mental disorders |
7 |
|
prenatal exposure |
7 |
|
prenatal exposure delayed effects |
7 |
|
probability |
7 |
|
psychiatric patients |
7 |
|
psychiatric symptomatology |
7 |
|
psychoeducation |
7 |
|
psychological distress |
7 |
|
psychosocial functioning |
7 |
|
psychotherapy - methods |
7 |
|
psychotic disorders - diagnosis - drug therapy - therapy |
7 |
|
psychotic disorders - diagnosis - psychology |
7 |
|
psychotic disorders - drug therapy |
7 |
|
ptsd symptoms, women mental health |
7 |
|
public health and safety |
7 |
|
pyrophosphatases - genetics - physiology |
7 |
|
quantitative trait loci |
7 |
|
randomized controlled trials |
7 |
|
randomized controlled trials as topic |
7 |
|
rats |
7 |
|
real-world |
7 |
|
real-world functioning |
7 |
|
receptors, cell surface - genetics - metabolism |
7 |
|
rehospitalization |
7 |
|
remission induction |
7 |
|
resilient |
7 |
|
resting state |
7 |
|
retrospective studies |
7 |
|
risk taking |
7 |
|
schizophrenia - complications - diagnosis - epidemiology - therapy |
7 |
|
schizophrenia - drug therapy |
7 |
|
schizophrenia - drug therapy - pathology |
7 |
|
schizophrenia-spectrum disorder |
7 |
|
schizophrenia-spectrum disorders |
7 |
|
seasons |
7 |
|
seer program |
7 |
|
self-differentiation |
7 |
|
sequence analysis |
7 |
|
signal transduction - genetics |
7 |
|
six elements |
7 |
|
sleep hygiene |
7 |
|
smartphone addiction |
7 |
|
social anxiety |
7 |
|
social class |
7 |
|
social stigma |
7 |
|
sociodemographic correlates |
7 |
|
sp1 transcription factor - genetics |
7 |
|
spinal diseases - genetics |
7 |
|
spontaneously reported symptoms |
7 |
|
statistics, nonparametric |
7 |
|
stress/burden |
7 |
|
stressful life event |
7 |
|
suicide, attempted - psychology |
7 |
|
symptom classification |
7 |
|
transcription factor ap-2 - genetics |
7 |
|
transfection |
7 |
|
treatment delay |
7 |
|
treatment-resistant schizophrenia |
7 |
|
triage |
7 |
|
ultra-high risk |
7 |
|
undercontrolled |
7 |
|
v266l |
7 |
|
valine |
7 |
|
variant prioritization |
7 |
|
vertebral disk displumbar vertebrae |
7 |
|
white matter integrity |
7 |
|
5' untranslated region |
6 |
|
actor-partner interdependence model |
6 |
|
adiponectin |
6 |
|
adiponectin - genetics |
6 |
|
adipose tissue - chemistry |
6 |
|
adrenomedullin |
6 |
|
affective psychoses |
6 |
|
aging - pathology |
6 |
|
aging in place |
6 |
|
alanine |
6 |
|
alff |
6 |
|
alzheimer disease - pathology |
6 |
|
anisotropy |
6 |
|
anorectal malformations |
6 |
|
anti-psychotics |
6 |
|
antidepressant |
6 |
|
antipsychotic agents - administration and dosage - therapeutic use |
6 |
|
app |
6 |
|
area under curve |
6 |
|
arhgap4 |
6 |
|
asia - epidemiology |
6 |
|
asociality |
6 |
|
at-risk mental states |
6 |
|
atherosclerosis |
6 |
|
at‐risk mental state |
6 |
|
autobiographical memory |
6 |
|
back pain - diagnosis - epidemiology |
6 |
|
benzodiazepine discontinuation |
6 |
|
biological markers - blood - metabolism |
6 |
|
biomedicine |
6 |
|
blinking |
6 |
|
blood glucose - analysis |
6 |
|
bone density |
6 |
|
bone loss |
6 |
|
bone mineral testing |
6 |
|
brain - drug effects - metabolism - pathology |
6 |
|
burkholderia pseudomallei |
6 |
|
cancer stem cell |
6 |
|
cancer stemness |
6 |
|
carcinoma, papillary - genetics - metabolism - pathology |
6 |
|
cardiovascular diseases - mortality |
6 |
|
carrier proteins - genetics |
6 |
|
category fluency |
6 |
|
cause of death |
6 |
|
cbt |
6 |
|
cell adhesion molecules - blood |
6 |
|
cell proliferation |
6 |
|
cell transformation, neoplastic - genetics - metabolism |
6 |
|
checklist |
6 |
|
child psychiatry |
6 |
|
childhood trauma |
6 |
|
chinese herbal medicine |
6 |
|
chinese zodiac signs |
6 |
|
chizophrenia |
6 |
|
choledochal cyst |
6 |
|
chromosome 8p |
6 |
|
chromosomes, human, pair 3 - genetics |
6 |
|
chromosomes, human, pair 9 |
6 |
|
chronological age |
6 |
|
clinical high‐risk |
6 |
|
clinical predictors |
6 |
|
clozapine-resistant schizophrenia |
6 |
|
clustering |
6 |
|
cognition disorders - psychology |
6 |
|
cognitive aging |
6 |
|
cognitive clusters |
6 |
|
cognitive functioning |
6 |
|
cognitive heterogeneity |
6 |
|
cognitive insights |
6 |
|
col9a2 |
6 |
|
col9a3 |
6 |
|
collagen |
6 |
|
collagen type ix - genetics |
6 |
|
communityolder |
6 |
|
complete |
6 |
|
compliance |
6 |
|
concepts |
6 |
|
confounding |
6 |
|
contact tracing |
6 |
|
coping styles |
6 |
|
cox model |
6 |
|
cross infection - epidemiology - prevention & control - transmission |
6 |
|
cultural sensitivity |
6 |
|
cytokines - genetics |
6 |
|
data mining |
6 |
|
data repository |
6 |
|
de novo |
6 |
|
delivery of health care - standards |
6 |
|
demography |
6 |
|
depressive symptons |
6 |
|
diabetes mellitus, type 2 - diagnosis - ethnology - genetics |
6 |
|
dibenzothiazepines - therapeutic use |
6 |
|
diffusivity |
6 |
|
digit symbol test |
6 |
|
digital technologies |
6 |
|
disease outbreaks |
6 |
|
disease outbreaks - prevention & control - statistics & numerical data |
6 |
|
dna-binding proteins - genetics - metabolism |
6 |
|
donepezil |
6 |
|
down syndrome |
6 |
|
drug naïve |
6 |
|
dysglycemia |
6 |
|
early intervention service |
6 |
|
early medical intervention - standards |
6 |
|
effect modification |
6 |
|
effort allocation |
6 |
|
effort discounting |
6 |
|
electroencephalography |
6 |
|
england - epidemiology |
6 |
|
environmental stressors |
6 |
|
erbb4 |
6 |
|
ethnic minority |
6 |
|
everyday cognitive function |
6 |
|
exon |
6 |
|
family functioning |
6 |
|
family history |
6 |
|
fiber tracking |
6 |
|
fibrinogen |
6 |
|
fibrinogen - genetics - metabolism |
6 |
|
fitmind |
6 |
|
founder mutation |
6 |
|
fractionation |
6 |
|
fractures, bone - genetics |
6 |
|
gamma-glutamyltransferase - blood - metabolism |
6 |
|
gender differences |
6 |
|
gene cluster |
6 |
|
genetic disease |
6 |
|
genetic epidemiology |
6 |
|
genetic linkage |
6 |
|
genetic linkage - genetics |
6 |
|
genome, human |
6 |
|
genome-wide haplotype association mapping (ham) |
6 |
|
germ-line mutation |
6 |
|
ggt |
6 |
|
gli3 |
6 |
|
global cognitive function |
6 |
|
global functioning |
6 |
|
glucose intolerance - blood - genetics |
6 |
|
goiter, nodular - genetics - metabolism - pathology |
6 |
